Involvement of glypican-1 autoprocessing in scrapie infection

被引:14
|
作者
Lofgren, Kajsa [2 ]
Cheng, Fang [1 ]
Fransson, Lars-Ake [1 ,2 ]
Bedecs, Katarina
Mani, Katrin [1 ]
机构
[1] Lund Univ, Dept Expt Med Sci, Div Neurosci, SE-22184 Lund, Sweden
[2] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
heparan sulphate; nitric oxide; prion; proteoglycan; recycling;
D O I
10.1111/j.1460-9568.2008.06386.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The copper-binding cellular prion protein (PrPC) and the heparan sulphate (HS)-containing proteoglycan glypican-1 (Gpc-1) can both be attached to lipid rafts via their glycosylphosphatidylinositol anchors, and copper ions stimulate their cointernalization from the cell surface to endosomes. The prion protein controls cointernalization and delivers copper necessary for S-nitrosylation of conserved cysteines in the Gpc-1 core protein. Later, during recycling through endosomal compartments, nitric oxide can be released from the S-nitroso groups and catalyses deaminative degradation and release of the HS substituents. Here, by using confocal immunofluorescence microscopy, we show that normal PrPC and Gpc-1 colocalize inside GT1-1 cells. However, in scrapie-infected cells (ScGT1-1), Gpc-1 protein remained at the cell surface separate from the cellular prion protein. Scrapie infection stimulated Gpc-1 autoprocessing and the generated HS degradation products colocalized with intracellular aggregates of the disease-related scrapie prion protein isoform (PrPSc). Coimmunoprecipitation experiments demonstrated an association between Gpc-1 and PrPC in uninfected cells, and between HS degradation products and PrPSc in infected cells. Silencing of Gpc-1 expression or prevention of Gpc-1 autoprocessing elevated the levels of intracellular PrPSc aggregates in infected cells. These results suggest a role for Gpc-1 autoprocessing in the clearance of PrPSc from infected cells.
引用
收藏
页码:964 / 972
页数:9
相关论文
共 50 条
  • [21] Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
    Sabanathan, Dhanusha
    Lund, Maria E.
    Campbell, Douglas H.
    Walsh, Bradley J.
    Gurney, Howard
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [22] Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent
    Litwack, ED
    Ivins, JK
    Kumbasar, A
    Paine-Saunders, S
    Stipp, CS
    Lander, AD
    DEVELOPMENTAL DYNAMICS, 1998, 211 (01) : 72 - 87
  • [23] S-Nitrosylation of secreted recombinant human glypican-1
    Gabriel Svensson
    Katrin Mani
    Glycoconjugate Journal, 2009, 26 : 1247 - 1257
  • [24] Glypican-1表达的研究现状与进展
    张立霞
    刘冬青
    生理科学进展, 2020, 51 (02) : 103 - 106
  • [25] Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma
    Qingcui Song
    Digestive Diseases and Sciences, 2019, 64 : 3355 - 3356
  • [26] Mechanisms underlying preferential assembly of heparan sulfate on glypican-1
    Chen, RL
    Lander, AD
    GLYCOBIOLOGY, 1999, 9 (10) : 1133 - 1133
  • [27] Role of glypican-1 in regulating multiple cellular signaling pathways
    Pan, Jiajia
    Ho, Mitchell
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 321 (05): : C846 - C858
  • [28] Glypican-1 as a target for fluorescence molecular imaging of bladder cancer
    Polikarpov, Dmitry M.
    Campbell, Douglas H.
    Zaslavsky, Alexander B.
    Lund, Maria E.
    Wu, Angela
    Lu, Yanling
    Palapattu, Ganesh S.
    Walsh, Bradley J.
    Zvyagin, Andrei, V
    Gillatt, David A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (12) : 1290 - 1297
  • [29] Heparan sulfate and glypican-1 mediate renal carcinoma metastasis
    Qazi, Henry
    Moran, Heriberto
    Cancel, Limary M.
    Mayer, Mariya
    Roberge, Sylvie
    Huang, Peigen
    Munn, Lance L.
    Tarbell, John M.
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker
    Diamandis, Eleftherios P.
    Plebani, Mario
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (01) : E1 - E2